<p>Patients with concurrent promoter methylation and LOH of <i>RASSF1A</i> showed the poorest over-all survival (<i>P</i> = 0.019) among the three groups.</p
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
Aberrant promoter methylation is known to silence tumor-suppressor genes in prostate cancer. Using a...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
<p>Patients with <i>RASSF1A</i> promoter methylation showed poorer over-all survival (A) (<i>P</i> <...
<p>The curves show CF-free survival of patients from the low (LM, <15% <i>GSTP1</i> methylation), mo...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<p>The Kaplan-Meier curves for genes (DSP, EPHB6, HCK, IL18, IRAK3 and KIT) whose hypermethylation w...
<p><i>CXCR4</i> methylation status and the correlation with (A) overall survival (OS) and (B) diseas...
CERVOXYInternational audienceThe aims of this study were to assess the frequency of promoter hyperme...
<p><b>A.</b> The sum of z-scores for RASSF1A, RARβ2 and CDH13 were significantly higher in AA patien...
<p>Kaplan–Meier estimates of overall survival by <i>SULF2</i> methylation status and clinical charac...
<p>The mean methylation level of 11 CpG sites was used. Cases were assigned into methylation high or...
<p>The summary HR and 95% CIs were shown (according to the random-effects estimations).</p
<p>The curves depicting the effects on postoperative recurrence of LINE-1 methylation when divided i...
<p>Kaplan-Meier survival curves were calculated for each of the tumor-specific hypermethylated genes...
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
Aberrant promoter methylation is known to silence tumor-suppressor genes in prostate cancer. Using a...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
<p>Patients with <i>RASSF1A</i> promoter methylation showed poorer over-all survival (A) (<i>P</i> <...
<p>The curves show CF-free survival of patients from the low (LM, <15% <i>GSTP1</i> methylation), mo...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<p>The Kaplan-Meier curves for genes (DSP, EPHB6, HCK, IL18, IRAK3 and KIT) whose hypermethylation w...
<p><i>CXCR4</i> methylation status and the correlation with (A) overall survival (OS) and (B) diseas...
CERVOXYInternational audienceThe aims of this study were to assess the frequency of promoter hyperme...
<p><b>A.</b> The sum of z-scores for RASSF1A, RARβ2 and CDH13 were significantly higher in AA patien...
<p>Kaplan–Meier estimates of overall survival by <i>SULF2</i> methylation status and clinical charac...
<p>The mean methylation level of 11 CpG sites was used. Cases were assigned into methylation high or...
<p>The summary HR and 95% CIs were shown (according to the random-effects estimations).</p
<p>The curves depicting the effects on postoperative recurrence of LINE-1 methylation when divided i...
<p>Kaplan-Meier survival curves were calculated for each of the tumor-specific hypermethylated genes...
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
Aberrant promoter methylation is known to silence tumor-suppressor genes in prostate cancer. Using a...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
DOI
Add to ORKG